SEBULSKY ALAN
SEC Form 4 insider trading activity
SEBULSKY ALAN has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jun 16, 2026.
On the most recent filing, SEBULSKY ALAN is listed as Director at Parabilis Medicines, Inc. Inside the rolling window, SEBULSKY ALAN reported 3 open-market purchases totaling $724K in PBLS and no open-market sales. The largest disclosed transaction in the window is a purchase of 12,500 PBLS shares on Jun 11, 2026, worth $250K.
Companies traded
Other insiders at PBLS
Insider Buying
$724K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has SEBULSKY ALAN made?
SEBULSKY ALAN has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does SEBULSKY ALAN trade?
SEBULSKY ALAN has filed SEC Form 4 disclosures for 1 company, including PBLS.
When was SEBULSKY ALAN's most recent SEC Form 4 filing?
SEBULSKY ALAN's most recent SEC Form 4 filing on Tracefour is dated Jun 16, 2026.
What is SEBULSKY ALAN's total buy and sell value in the current window?
Inside the rolling retention window, SEBULSKY ALAN bought $724K and sold $0 based on SEC Form 4 filings.
What was SEBULSKY ALAN's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 12,500 PBLS shares on 2026-06-11, worth $250K, per SEC Form 4 filings.